Effect of Remote Ischemic Preconditioning on Postoperative Complications in Visceral Surgery
- Conditions
- Postoperative Complication
- Interventions
- Device: RIPC with a tourniquet
- Registration Number
- NCT02375269
- Lead Sponsor
- University of Zurich
- Brief Summary
Remote Ischemic Preconditioning (RIPC) is mediated by intermittent brief episodes (5-10 minutes) of short ischemia in a limb (i.e. arm), followed by reperfusion. For this purpose in 3-4 cycles, a tourniquet is insufflated to suprasystolic pressure levels for 5 minutes and deflated for 5 minutes afterwards. The ischemic episodes are known to stimulate platelets and factors platelet dependent factors such as Serotonin and VEGF. These humoral factors have a systemic effect and have the potential to protect target organs (i.e. heart, kidney, liver) remote to the ischemic limb.
The purpose of this randomized controlled study is to investigate the influence and impact of RIPC on postoperative complications in patients undergoing visceral surgery
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 526
- > 18 years
- Undergoing major visceral surgery
- < 18 years
- Pregnancy
- Signs of Infection/Inflammation on upper limb
- Shunt
- Medical history of axillary lymph node dissection
- Signs of malperfusion of upper limb (i.e. Allen Test)
- Missing informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description RIPC (Remote Ischemic Preconditioning) RIPC with a tourniquet Preoperatively in the operation theater a tourniquet will be applied to the left arm and RIPC will performed. Therefore the tourniquet will be insufflated to suprasystolic pressure levels for 5 minutes, followed by 5 minutes reperfusion (deflated). Three cycles are planned. Duration of the procedure is 30 minutes.
- Primary Outcome Measures
Name Time Method Postoperative Complications 30 days Complications will be assessed by Comprehensive Complication Index and Dindo Clavien Score
- Secondary Outcome Measures
Name Time Method ICU stay 30 days Infection composite parameters 30 days CRP, Procalcitonin, Leucocytes
Hospital stay 30 days
Trial Locations
- Locations (1)
Department of Surgery, Swiss HPB and Transplant Surgery, University Hospital Zurich
🇨ðŸ‡Zurich, Switzerland